Can New Leadership Rejuvenate Big Pharma?

Article Summary The last five years have not been great ones for the large-cap pharmaceutical space. Not only has the industry been tainted by high-profile safety scandals, but many would-be blockbuster drugs have failed late stage trials. While that has been going